Evidence map›Paper›PMID 40351481›Full record

ReviewCureus2025

Endocrine Disruptors and Their Impact on Quality of Life: A Literature Review.

Tane Del Río Barrera, Kemberly Noemi Zambrano Ledesma, Maricarmen Aguilar Hernández, Karla Reyes Chávez, Alejandro Fabricio Aguirre Barajas, Dania Patricia Alvarez Vázquez, Gerardo Garcia Santiago, Alejandra Arias Castro

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tane Del Río BarreraGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.
Kemberly Noemi Zambrano LedesmaGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.
Maricarmen Aguilar HernándezGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.
Karla Reyes ChávezGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.
Alejandro Fabricio Aguirre BarajasGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.
Dania Patricia Alvarez VázquezGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.
Gerardo Garcia SantiagoGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.
Alejandra Arias CastroGeneral Medicine, Universidad Autónoma de Guadalajara, Guadalajara, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine-disrupting chemicals (EDCs) are widespread environmental contaminants that interfere with hormonal regulation, affecting metabolism, reproduction, neurodevelopment, and overall health. This review presents an overview of recent evidence on the health effects and biological mechanisms of EDCs, with a focus on their impact on hormonal balance and quality of life. An integrative literature review was conducted using 28 peer-reviewed articles published between 2020 and 2025, retrieved from databases such as PubMed, Scopus, and ScienceDirect. The selected studies explored the physiological and pathological effects of EDCs in humans. Compounds, such as bisphenol A, phthalates, and polychlorinated biphenyls (PCBs), can mimic or block hormones, disrupt endocrine signaling pathways, and bioaccumulate in tissues. Exposure, especially during critical developmental windows, is linked to metabolic disorders, infertility, neurodevelopmental delays, and hormone-sensitive cancers. Common exposure sources include food, air, household dust, water, and personal care products. Key mechanisms of action involve receptor binding interference, oxidative stress, and epigenetic alterations. EDCs pose a significant and growing threat to public health, warranting urgent regulatory measures, increased public awareness, and continued research to mitigate long-term health consequences.

Indexed as

endocrine disruptorsenviromental exposurehormonal imbalancemetabolic disordersreproductive health

Identifiers

PMID40351481
PMCPMC12066167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.